Peter R. Manninen
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Synthesis of β-Lactam Compounds, Synthesis and biological activity, HIV/AIDS drug development and treatment, Drug Transport and Resistance Mechanisms, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections(1996)572 cited
- → Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections(2008)195 cited
- → Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia(2015)57 cited
- → Synthesis and antibacterial activity of [6,5,5] and [6,6,5] tricyclic fused oxazolidinones(1998)35 cited
- → Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1(2016)27 cited
- → Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors(2016)26 cited
- → Asymmetric Synthesis of the C3α Fragment of 5,6-Dihydro-α-pyrone Nonpeptidic HIV-1 Protease Inhibitors(1999)19 cited
- → N-Acyl 3-alkylidenyl- and 3-alkyl azetidin-2-ones: A new class of monocyclic .BETA.-lactam antibacterial agents. 1. Structure-activity relationships of 3-isopropylidene and 3-isopropyl analogs.(1992)13 cited
- → 7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: Synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase(2007)13 cited
- → N-acyl-3-alkylidenyl- and 3-alkyl azeitidin-2-ones: a new class of monocyclic β-lactam antibacterial agents 2. Synthesis and structure-activity relationships of heteroatom substituted 3-isopropylidene and 3-isopropyl analogs(1993)10 cited